These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 660008)

  • 21. [Combination chemotherapy in advanced carcinoma of the breast].
    Carmo-Pereira J; Galvão-Teles A; Oliveira Costa F; Bak Gordon R; Henriques E; Dória JM; Freire Cruz M; Silveira Botelho L
    Arq Patol; 1974; 46(2-3):309-23. PubMed ID: 4458643
    [No Abstract]   [Full Text] [Related]  

  • 22. Sequential hormone-chemotherapy (MAP at high doses and CMF) in metastatic breast cancer. Preliminary results.
    Pannuti F; Di Marco AR; Rossi AP; Rocchetta G; Rubino I; Giovannini M; Fruet F
    Panminerva Med; 1981; 23(2):93-6. PubMed ID: 6459558
    [No Abstract]   [Full Text] [Related]  

  • 23. [Combination chemotherapy with cyclophosphamide, methotrexate, 5-fluoro-uracil, and vincristine in solid metastasized tumours (author's transl)].
    Castor H; Fritsch H; Drings P; Moskwa G; von Kaick G
    Med Klin; 1974 Apr; 69(17):750-6. PubMed ID: 4837493
    [No Abstract]   [Full Text] [Related]  

  • 24. Combination chemotherapy for disseminated carcinoma of the breast.
    Lozada JA; Grillo-López A; Vélez-Garciá E
    Bol Asoc Med P R; 1975 Jun; 67(6):157-63. PubMed ID: 1055588
    [No Abstract]   [Full Text] [Related]  

  • 25. Grand Rounds: Adjuvant therapy of breast cancer.
    Va Med; 1977 Oct; 104(10):709-15. PubMed ID: 919723
    [No Abstract]   [Full Text] [Related]  

  • 26. Combination chemotherapy with 5--fluorouracil, amethopterin (methotrexate) and prednisolone (FAP protocol) in the therapy of cholangiocarcinoma.
    Umsawasdi T; Chainuvati T; Hitanant S; Nilprabhassorn P; Viranuvatti V
    J Med Assoc Thai; 1976 Aug; 59(8):380-3. PubMed ID: 184225
    [No Abstract]   [Full Text] [Related]  

  • 27. Chemotherapy in breast cancer.
    Hanham IW
    Proc R Soc Med; 1974 Apr; 67(4):292-4. PubMed ID: 4453579
    [No Abstract]   [Full Text] [Related]  

  • 28. [Possibilities of cytostatic effects on brain metastasis].
    Krauseneck P; Lipp F; Dommasch D
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1231-4. PubMed ID: 611823
    [No Abstract]   [Full Text] [Related]  

  • 29. [Combination chemo-endocrine therapy of metastatic and stage IV breast cancer with cyclophosphamide, adriamycin, prednisolone and tamoxifen (CAPT)--with special reference to management of brain and liver metastasis].
    Nakamura Y; Kawaguchi M; Hata A; Watanabe H; Ueki Y; Oribe T; Koba F; Takamuku K
    Gan To Kagaku Ryoho; 1989 Feb; 16(2):243-50. PubMed ID: 2919892
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combination chemotherapy with methotrexate (NSC-740), adriamycin (NSC-123127), cyclophosphamide (NSC-26271), and 5-fluorouracil (NSC19893) for adult solid tumors.
    Stephens RL; Hoogstraten B
    Cancer Chemother Rep; 1974; 58(6):943-5. PubMed ID: 4614901
    [No Abstract]   [Full Text] [Related]  

  • 31. [Cytostatic treatment of metastasizing breast cancer. A prospective controlled comparison between single drug and multiple drug chemotherapy].
    Mouridsen HT; Palshof T; Brahm M; Rahbek I
    Ugeskr Laeger; 1977 Oct; 139(44):2632-5. PubMed ID: 929742
    [No Abstract]   [Full Text] [Related]  

  • 32. [Sequential combination chemotherapy in metastatic cancer of the breast].
    Leone BA; Rabinovich MG; Strauss E; Arévalo E
    Medicina (B Aires); 1984; 44(1):15-22. PubMed ID: 6549523
    [No Abstract]   [Full Text] [Related]  

  • 33. Variations in responsiveness and survival of clinical subsets of patients with metastatic breast cancer to two chemotherapy combinations.
    Smalley RV; Bartolucci AA
    Eur J Cancer (1965); 1980; Suppl 1():141-6. PubMed ID: 7318861
    [No Abstract]   [Full Text] [Related]  

  • 34. A phase II trial of cyclophosphamide, methotrexate, 5-fluorouracil, and prednisolone rapidly alternating with doxorubicin and vincristine (CMFP/AV) in advanced breast cancer.
    Rischin D; Bishop JF; Olver IN; Laidlaw CR; Zimet A; Jeal P; Dipell JF
    Am J Clin Oncol; 1992 Oct; 15(5):392-4. PubMed ID: 1524039
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of hepatic metastases from breast cancer.
    Bugarski M; Vuletić L; Boberić J; Milosavljević A; Dilparić S; Tomin R; Naumović P
    Clin Oncol; 1978 Jun; 4(2):167-71. PubMed ID: 668248
    [No Abstract]   [Full Text] [Related]  

  • 36. [High-dose chemotherapy for metastatic breast cancer without certain advantages so far].
    Kleeberg UR
    Strahlenther Onkol; 2000 Jul; 176(7):334-5. PubMed ID: 10963001
    [No Abstract]   [Full Text] [Related]  

  • 37. Chemotherapy of breast cancer.
    Mitchell MS
    Conn Med; 1975 Jan; 39(1):4-5. PubMed ID: 1109851
    [No Abstract]   [Full Text] [Related]  

  • 38. [Combined leukeran-prednisolone therapy in metastasizing breast cancer].
    Cziráki L; Oó M
    Fortschr Med; 1977 Apr; 95(15):1043-6. PubMed ID: 858580
    [No Abstract]   [Full Text] [Related]  

  • 39. Adjuvant treatment in operable breast cancer.
    O'Brien PH
    J S C Med Assoc; 1976 May; 72(5):173-4. PubMed ID: 1063901
    [No Abstract]   [Full Text] [Related]  

  • 40. Phase II study of mitolactol in chemotherapy-refractory metastatic breast cancer.
    Creech RH; Catalano RB; Dierks KM; Shah MK
    Cancer Treat Rep; 1984 Dec; 68(12):1499-501. PubMed ID: 6548936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.